{"id":163774,"date":"2014-12-04T09:46:18","date_gmt":"2014-12-04T14:46:18","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/mini-chromosomes-that-strengthen-tumors.php"},"modified":"2014-12-04T09:46:18","modified_gmt":"2014-12-04T14:46:18","slug":"mini-chromosomes-that-strengthen-tumors","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/mini-chromosomes-that-strengthen-tumors.php","title":{"rendered":"Mini chromosomes that strengthen tumors"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    4-Dec-2014  <\/p>\n<p>    Contact: Federico Santoni    <a href=\"mailto:federico.santoni@unige.ch\">federico.santoni@unige.ch<\/a>    022-379-5719    Universit de Genve    @UNIGEnews<\/p>\n<p>    Cancers are due to genetic aberrations in certain cells that    gain the ability to divide indefinitely. This proliferation of    sick cells generates tumors, which gradually invade healthy    tissue. Therefore, current therapies essentially seek to    destroy cancer cells to stop their proliferation. Through    high-throughput genetic sequencing of glioblastoma cells, one    of the most deadly brain tumors, a team of geneticists from the    University of Geneva's (UNIGE) Faculty of Medicine discovered    that some of these mutations are caused by supplemental    extrachromosomal DNA fragments, called double minutes, which    enable cancer cells to better adapt to their environment and    therefore better resist to treatments meant to destroy them.    Read more in Nature Communications.  <\/p>\n<p>    Although scientists have known for about twenty years about    double minutes, little chromosomal fragments which sometimes    appear during cellular division, they have just started to    understand their exact function. Due to replication errors,    these mini-chromosomes lack centromere, which allows them to    replicate extremely rapidly and autonomously. Scientists    therefore suspect that they play a role in the development of    cancers, diseases that are caused by mutations in genes that    control cellular metabolism and development.  <\/p>\n<p>    Professor Stylianos Antonarakis and his team in the Genetic    Medicine and Development Department of UNIGE's Faculty of    Medicine, in collaboration with the Geneva University    Hospitals' (HUG) Centre of Oncology, identified double minutes    in glioblastoma cells with specific oncogenes. To this end, the    scientists used advanced methods of bioinformatics to perform    high-throughput genetic sequencing. The researchers then    noticed that one of the main genetic mutations responsible for    the anarchic development of cancer cells was not found on    actual chromosomes, but only on these double minutes, which,    given their very fast proliferation, multiplied the impact of    this mutation. The researchers had therefore identified an    oncogene whose malignancy was amplified by the number of its    copies present on each double minute, but which was not present    on the chromosomes themselves.  <\/p>\n<p>    An Intriguing Adaptability in DNA  <\/p>\n<p>    The Geneva team also discovered that cells can modulate the    number of double minutes according to their environment, and    especially in response to chemotherapy. To counter the    aggression caused by these treatments and ensure its survival,    the cell reduces its number of double minutes until they    disappear completely. It is thus freed from the oncogenetic    mutation that was present in these DNA fragments. But    glioblastoma, like most cancers, depends on a combination of    several genes. The tumor therefore begins to exploit a new gene    in order to keep growing. Paradoxically, the cell can return    to its initial chromosomal state with regards to that specific    oncogene, but other oncogenic genes are then activated in the    still living cell. The double minutes therefore act as    adjustment variables in cancer cells and limit the effects of    therapies, explains Sergei Nikolaev, joint lead author of the    study.  <\/p>\n<p>    These mini-chromosomes amplify the harmful effects of oncogenes    and give a selective advantage to sick cells compared with    healthy cells, as the tumor grows. In fact, their presence has    been detected in most very aggressive cancers. We must    absolutely continue our research in order to better understand    this phenomenon of DNA adaptation, emphasizes Federico    Santoni, joint lead author of this study. This will allow us    to better measure its implications, and perhaps to find more    effective therapeutic strategies against the deadliest    cancers, he concludes.  <\/p>\n<p>    ###  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original post:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-12\/udg-mct120214.php\/RK=0\/RS=itMHAYwm_rG4p3Nof_r5Cy79wzM-\" title=\"Mini chromosomes that strengthen tumors\">Mini chromosomes that strengthen tumors<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 4-Dec-2014 Contact: Federico Santoni <a href=\"mailto:federico.santoni@unige.ch\">federico.santoni@unige.ch<\/a> 022-379-5719 Universit de Genve @UNIGEnews Cancers are due to genetic aberrations in certain cells that gain the ability to divide indefinitely. This proliferation of sick cells generates tumors, which gradually invade healthy tissue <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/mini-chromosomes-that-strengthen-tumors.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-163774","post","type-post","status-publish","format-standard","hentry","category-genetic-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163774"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=163774"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163774\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=163774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=163774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=163774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}